The Board of Directors of Blue Jet Healthcare Limited will hold a meeting on November 4, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (Q2). A limited review report from the statutory auditor has been received. The trading window will reopen on November 7, 2025.
Board Meeting Announcement
Blue Jet Healthcare Limited has announced an upcoming meeting of its Board of Directors to review the company’s financial performance.
Financial Results on the Agenda
The primary agenda item for the meeting, scheduled for November 4, 2025, is the approval of the unaudited standalone financial results for the second quarter (Q2) and half year which ended on September 30, 2025. The board will consider the limited review report which was prepared by the company’s statutory auditor.
Trading Window Closure
As per company policy, the trading window for dealing in the company’s securities has been closed for designated persons and their immediate relatives. It will remain closed until 48 hours after the declaration of the financial results. Consequently, the trading window will reopen on November 7, 2025.
Source: BSE
